Journal of Cardiothoracic Surgery

FEBRUARY 19, 2025

Patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) face high mortality rates. Extracorporeal Membrane Oxygenation (ECMO) therapy offers critical support in these cases, yet i.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Risk Factors Research 52

Cardiovascular Diabetology

OCTOBER 29, 2024

Type 2 diabetes has traditionally been a risk factor for worse prognosis after myocardial infarction (MI), but major advances have been made in its treatment, and the use of secondary preventive measures has i.

Myocardial Infarction 52

Myocardial Infarction Diabetes Risk Factors Research 52

Journal of the American Heart Association

MARCH 26, 2025

Multivariable logistic regression models were used to estimate BMIstratified associations between SMuRFless status and outcomes.ResultsThe study included 44 538 patients with firstpresentation acute myocardial infarction, of whom 4454 were SMuRFless. Journal of the American Heart Association, Ahead of Print.

Myocardial Infarction 40

Myocardial Infarction Risk Factors BMI Obesity 40

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Background and objectives Hypertension is one of the most serious risk factors and the leading cause of mortality in patients with cardiovascular diseases (CVDs). It is necessary to accurately predict the mortality of patients suffering from CVDs with hypertension. Methods The synopsis of our research is as follows.

Myocardial Infarction 64

Myocardial Infarction Hypertension Risk Factors Cardiovascular Disease 64

Med Page Today

FEBRUARY 14, 2025

(MedPage Today) -- The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk patients with type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular risk factors, a prespecified.

Kidney Disease 83

Kidney Disease Heart attacks Heart Attack Diabetes 83

Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2025

We present the case of an 80-year-old woman with a small aortic annulus who underwent TAVR using a self-expanding transcatheter heart valve Acurate Neo2 after an non-ST-segment elevation myocardial infarction (NSTEMI) presentation.

Aortic valve 52

Aortic valve Aortic TAVR Myocardial Infarction 52

NEJM Journal Watch - Cardiology

JULY 11, 2024

Another study supports an association between influenza and subsequent MI.

Myocardial Infarction 45

Myocardial Infarction Risk Factors 45

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction Differences in pathophysiology, clinical presentation, and natural course of ST-elevation myocardial infarction in female patients due to either spontaneous dissection (SCAD-STEMI) or atherothrombotic occlusion (type 1 STEMI) have been discussed.

Myocardial Infarction 59

Myocardial Infarction SCAD STEMI Thrombolysis 59

Frontiers in Cardiovascular Medicine

JANUARY 3, 2024

Background Microcirculatory dysfunction is an independent risk factor for a poor prognosis after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI). Cardiac function was measured by echocardiography during hospitalization and follow-up.

Myocardial Infarction 59

Myocardial Infarction Outcomes Cardiac Function Thrombolysis 59

Frontiers in Cardiovascular Medicine

JANUARY 19, 2025

IntroductionHypoxic liver injury (HLI) and Killip classification are poor prognostic factors in patients with ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 52

Myocardial Infarction STEMI Biomarkers Hospital 52

Journal of the American Heart Association

MARCH 27, 2025

BackgroundRecent evidence highlights an increasing incidence of myocardial infarction in young women. years]) admitted to the China Chest Pain Center Database between 2016 and 2021.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Journal of the American Heart Association

FEBRUARY 26, 2025

A 2sample Mendelian randomization approach was applied to assess these associations, while multivariate Mendelian randomization and mediation analyses investigated the role of lipids in mediating the effects of diet on myocardial infarction.

Myocardial Infarction 40

Myocardial Infarction Cholesterol Diet Risk Factors 40

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Background and aims In the non-metropolitan region of Brandenburg (Germany), which is characterized by high rates of cardiovascular diseases and underserved medical care, there is a lack of awareness regarding lipoprotein(a) [Lp(a)] as a risk factor. vs. 53.2%, p  = 0.014) and myocardial infarction (24.7% vs. 5.5.%,

Risk Factors 59

Risk Factors Cardiovascular Disease Peripheral Arterial Disease Coronary Artery Disease 59

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Early ventricular tachycardia/fibrillation (VT/VF) in patients with ST-elevation myocardial infarction (STEMI) has higher morbidity and mortality. This study examines gender-differentiated risk factors and underlying mechanisms for early onset VT/VF in STEMI.

Myocardial Infarction 59

Myocardial Infarction STEMI Defibrillator Diet 59

Circulation

NOVEMBER 11, 2024

Owing to improved management, the life expectancy of patients with hemophilia has increased significantly and predisposes them to risk of cardiovascular diseases and thrombotic events. The primary outcome was to estimate the prevalence of cardiovascular risk factors in patients with hemophilia compared to the general population.

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

DAIC

APRIL 6, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

Heart attacks 52

Heart attacks Heart Attack Risk Factors Research 52

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

BackgroundCurrent research suggests that microvascular obstruction (MVO) following the first percutaneous coronary intervention (PCI) in myocardial infarction patients is closely related to inflammatory responses. However, the relationship between LCR and MVO remains unclear.

Myocardial Infarction 40

Myocardial Infarction STEMI Risk Factors Research 40

Journal of the American Heart Association

FEBRUARY 14, 2025

BackgroundPlasma protein alterations may occur in patients with acute myocardial infarction (AMI). Univariate and multivariate logistic regression analyses indicated that TMSB4 is a risk factor for firstonset AMI. Journal of the American Heart Association, Ahead of Print.

Myocardial Infarction 40

Myocardial Infarction Risk Factors 40

European Journal of Heart Failure

JANUARY 14, 2025

The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI). Methods and results The International Registry of MitraClip in Acute Mitral Regurgitation following Acute Myocardial Infarction (IREMMI) includes 187 patients with severe MR post-MI managed with TEER.

Myocardial Infarction 40

Myocardial Infarction Bicuspid/Mitral Cardiogenic Shock Risk Factors 40

Journal of the American Heart Association

FEBRUARY 28, 2024

We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.

Myocardial Infarction 76

Myocardial Infarction Outcomes Heart Disease Strokes 76

Journal of the American Heart Association

FEBRUARY 8, 2025

BackgroundUnrecognized or silent myocardial infarction (MI) detected on an ECG is associated with firstever stroke, but the impact on stroke recurrence is unknown. Journal of the American Heart Association, Ahead of Print. The primary outcome was recurrent stroke. Ischemic stroke and subtype were assessed as secondary outcomes.

Myocardial Infarction 40

Myocardial Infarction Strokes Stroke Risk Factors 40

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

The Lasso regression was used to preliminarily screen potential risk factors, which were entered into the multivariable logistic regression analysis to identify preoperative independent risk factors for postoperative AKI. Results220 patients (36.2%) developed AKI after surgery. and 63.4%, respectively.

Heart Valves 40

Heart Valves Risk Factors Cerebrovascular Disease Myocardial Infarction 40

Coronary Artery Disease Journal

MAY 29, 2024

Background Despite advances in percutaneous coronary intervention (PCI) for ST segment elevation myocardial infarction (STEMI), in-hospital mortality remains a concern, highlighting the need for the identification of additional risk factors such as serum iron levels. μmol/L) and a control group (Fe ≥7.8 μmol/L).

Myocardial Infarction 40

Myocardial Infarction Hospital STEMI Risk Factors 40

Frontiers in Cardiovascular Medicine

JANUARY 25, 2024

Ischemic injury, also called myocardial injury after non-cardiac surgery (MINS), is further classified into perioperative myocardial infarction or myocardial injury without infarction. Classifying perioperative myocardial injury further is particularly important for clinical management and prognosis.

Myocardial Infarction 64

Myocardial Infarction Physiology Tachycardia Risk Factors 64

Coronary Artery Disease Journal

JANUARY 11, 2024

Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) covers an expanding group of patients over recent years. Previous studies showed considerable risks of outcomes in this group. We performed the Cox regression analysis to investigate the risk factors for mortality.

Myocardial Infarction 40

Myocardial Infarction Outcomes Atrial Fibrillation Risk Factors 40

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 5, 2023

BACKGROUND:Canadian data suggest that patients of lower socioeconomic status with acute myocardial infarction receive less beneficial therapy and have worse clinical outcomes, raising questions regarding care disparities even in universal health care systems. Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Myocardial Infarction 40

Myocardial Infarction Hospital Outcomes Risk Factors 40

Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other cardiovascular risk factors, the.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction Risk Factors Outcomes 52

Coronary Artery Disease Journal

APRIL 24, 2024

Purpose Construction of a prediction model to predict the risk of major adverse cardiovascular events (MACE) in the long term after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI).

Myocardial Infarction 40

Myocardial Infarction STEMI Diabetes Hypertension 40

HeartRhythm

MARCH 24, 2025

Little is known about the risk factors and prognosis of new-onset atrial fibrillation (NOAF) in patients with primary percutaneous coronary intervention (PCI).

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Risk Factors Outcomes 40

Circulation: Cardiovascular Imaging

APRIL 3, 2025

BACKGROUND:Microvascular obstruction (MVO) is associated with heart failure (HF) following ST-segmentelevation myocardial infarction. Circulation: Cardiovascular Imaging, Ahead of Print. AMR, whether as a continuous (per 0.5-mm mm Hg*s/cm increase; hazard ratio, 1.29 [95% CI, 1.101.52];P=0.002) or categorical (AMR >2.7

Heart Failure 40

Heart Failure Myocardial Infarction STEMI Risk Factors 40

Coronary Artery Disease Journal

APRIL 28, 2024

No abstract available

Myocardial Infarction 40

Myocardial Infarction Risk Factors Hemorrhage Research 40

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) - A Double-blind, Randomized Placebo Procedure-controlled Trial of an Interatrial Shunt in Patients with HFrEF and HFpEF: Principal Results From the RELIEVE-HF Trial - Empagliflozin After Acute Myocardial Infarction: Results of the EMPACT-MI Trial - CSL112 (Apolipoprotein A-I) Infusions and Cardiovascular Outcomes in Patients (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Open Heart

JUNE 5, 2024

Background There is increasing awareness that patients without standard modifiable risk factors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). vs 3.9%, p<0.001) and ST-elevation myocardial infarction (59.1%

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Outcomes Coronary Artery Disease 52

Stroke Journal

DECEMBER 5, 2024

We further compared our findings with the adherence observed among myocardial infarction (MI) survivors and healthy adults, each assessed against distinct physical activity guidelines specific to their respective populations.METHODS:We utilized data from the 2011 to 2019 Behavioral Risk Factor Surveillance System, a nationally representative survey.

Strokes 75

Strokes Stroke Myocardial Infarction Education 75

Heart BMJ

APRIL 25, 2024

We investigated whether genetic liability to pre-eclampsia/eclampsia and gestational hypertension is associated with CVD risk factors and occurrence of CVD events. In our primary analysis, we applied Mendelian randomisation using inverse-variance weighted regression analysis in ever pregnant women.

Cardiovascular Disease 52

Cardiovascular Disease Hypertension Blood Pressure Myocardial Infarction 52

Heart BMJ

MAY 10, 2024

Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heart failure and myocardial infarction.

Arrhythmia 40

Arrhythmia Myocardial Infarction Atrial Fibrillation Heart Failure 40

Circulation: Genomic and Precision Medicine

JANUARY 23, 2025

BACKGROUND:Established risk models may not be applicable to patients at higher cardiovascular risk with a measured Lp(a) (lipoprotein[a]) level, a causal risk factor for atherosclerotic cardiovascular disease.METHODS:This was a model development study. Circulation: Genomic and Precision Medicine, Ahead of Print.

Myocardial Infarction 40

Myocardial Infarction Risk Factors Thrombolysis Circulation 40